Rappta Therapeutics

Recent Finacing

Series A

Recent Raise

$10.6M

Rappta Therapeutics is a private biotech company developing PP2A-activating anti-cancer drugs by translating PP2A structural and biological insights into therapeutics, operating in Finland and the US.

Founded 2006

Southern Finland, Finland

11-50

Private

rappta-therapeutics.com

Highlights

Focus Areas

Biopharma

Biotechnology

Life Science

Recent Investors

Financials

$10.6M

Total Raised

1

Funding round

4

Investors

Team

Upgrade to view the team

See the team members at Rappta Therapeutics.